SCFβ-TRCPsuppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2

Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

(2011) Debyani Chakravarty et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeted therapies for thyroid tumors

(2011) Steven I Sherman   MODERN PATHOLOGY

PEST Motif Serine and Tyrosine Phosphorylation Controls Vascular Endothelial Growth Factor Receptor 2 Stability and Downregulation

(2011) R. D. Meyer et al.   MOLECULAR AND CELLULAR BIOLOGY

Metastatic Dormancy and Progression in Thyroid Cancer: Targeting Cells in the Metastatic Frontier

(2011) Matthew D. Ringel   THYROID

Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase

(2010) Hiroyuki Inuzuka et al.   CANCER CELL

Targeting Vascular Endothelial Growth Factor Receptor in Thyroid Cancer: The Intracellular and Extracellular Implications

(2010) S. M. Keefe et al.   CLINICAL CANCER RESEARCH

Spermatogenesis rescue in a mouse deficient for the ubiquitin ligase SCF -TrCP by single substrate depletion

(2010) N. Kanarek et al.   GENES & DEVELOPMENT

BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus

(2010) Dingxie Liu et al.   INTERNATIONAL JOURNAL OF CANCER

Treatment with Tyrosine Kinase Inhibitors for Patients with Differentiated Thyroid Cancer: the M. D. Anderson Experience

(2010) Maria E. Cabanillas et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer

(2010) Elaine T. Lam et al.   JOURNAL OF CLINICAL ONCOLOGY

Mechanisms of Vascular Aging: New Perspectives

(2010) Z. Ungvari et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

B-RafV600E and thrombospondin-1 promote thyroid cancer progression

(2010) C. Nucera et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Stabilization of VEGFR2 Signaling by Cerebral Cavernous Malformation 3 Is Critical for Vascular Development

(2010) Y. He et al.   Science Signaling

Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets

(2009) Jeffrey A Knauf et al.   CURRENT OPINION IN CELL BIOLOGY

Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis

(2009) Cristina Rodríguez-Antona et al.   ENDOCRINE-RELATED CANCER

Phase II Trial of Sorafenib in Metastatic Thyroid Cancer

(2009) Richard T. Kloos et al.   JOURNAL OF CLINICAL ONCOLOGY

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

(2008) Ezra E.W. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Sorafenib in Advanced Thyroid Cancer

(2008) Vandana Gupta-Abramson et al.   JOURNAL OF CLINICAL ONCOLOGY